Kairos Pharma, LTD. Quarterly Common Stock, Shares, Outstanding from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kairos Pharma, LTD. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2023 to Q4 2024.
  • Kairos Pharma, LTD. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 13.7M shares, a 30% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 13.7M +3.17M +30% Dec 31, 2024 10-K 2025-04-15
Q3 2024 12.8M Sep 30, 2024 10-Q 2024-11-14
Q4 2023 10.6M Dec 31, 2023 10-K 2025-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.